Hints and tips:
...Apax is confident of raising a similar-sized fund to its last one, thanks to the €3.4bn it has returned to investors from realisations this year, including the $1.2bn sale of Qualitest Pharmaceuticals, the...
...Apax Partners of the UK has made a return of about 1.7 times its initial investment from the $1.2bn sale of Qualitest Pharmaceuticals, the US generic drugmaker, to its Nasdaq-listed rival Endo Pharmaceuticals...
...In deals news, Endo Pharmaceuticals Holdings surged 8.1 per cent to $33.10 after it said it will buy privately owned generic drug manufacturer Qualitest Pharmaceuticals for about $1.2bn....
International Edition